electroCore

electroCore, Inc. is a U.S.-based neuroscience and bioelectronic healthcare technology company dedicated to improving patient outcomes through technological advancements. The company focuses on developing its proprietary non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of various conditions in neurology, metabolic disorders, and immunology. Its initial target is the treatment of primary headaches, particularly migraine and cluster headaches, as well as associated chronic comorbidities related to gastric motility, psychiatry, sleep, and pain, which impose disproportionately high direct and indirect costs on the healthcare system and society.